Trademark: 78676399
Word
RELZIQ
Status
Dead
Status Code
606
Status Date
Thursday, July 12, 2007
Serial Number
78676399
Mark Type
4000
Filing Date
Friday, July 22, 2005
Published for Opposition
Tuesday, April 18, 2006
Abandoned Date
Thursday, July 12, 2007

Trademark Owner History
Eli Lilly and Company - Owner At Publication

Classifications
5 Pharmaceutical and medicinal preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous system diseases and disorders, dermatological disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, and urological disorders

Trademark Events
Dec 28, 2007
Abandonment Notice Mailed - No Use Statement Filed
Dec 7, 2007
Abandonment - No Use Statement Filed
Mar 16, 2007
Extension 1 Granted
Jan 8, 2007
Extension 1 Filed
Jan 8, 2007
Teas Extension Received
Sep 15, 2006
Assigned To Examiner
Jul 11, 2006
Noa Mailed - Sou Required From Applicant
Apr 18, 2006
Published For Opposition
Mar 29, 2006
Notice Of Publication
Mar 2, 2006
Law Office Publication Review Completed
Feb 24, 2006
Assigned To Lie
Feb 17, 2006
Approved For Pub - Principal Register
Feb 17, 2006
Examiner's Amendment Entered
Feb 17, 2006
Examiners Amendment E-Mailed
Feb 17, 2006
Examiners Amendment -Written
Feb 9, 2006
Assigned To Examiner
Jul 29, 2005
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24